Progress and Problems in the Prescribing/Dispensing Split and "Divided Package Sales" by Wholesalers
スポンサーリンク
概要
- 論文の詳細を見る
Given the rapid progress of the prescribing/dispensing split, the ability of pharmacies to obtain and stock a small quantity of pharmaceuticals is seen as essential. Toho Yakuhin’s experience in “divided package sales” (wholesalers open an original package supplied by the manufacturer and sell only a part of the contents) shows that the number of orders and sales amount, and the number of pharmacies ordering in sales have remarkably increased. One or two kinds of pharmaceuticals were ordered in 73% cases, and one or two units in about 50%. This implies that “divided package sales” are utilized to obtain rarely prescribed drugs. On the other hand, five or more kinds of pharmaceuticals were ordered in 10% of cases, and ten or more units in 17%. “Divided package sales” were more used for low-price drugs. These indicated that “divided package sales” seemed to be looked upon by pharmacies as a means of obtaining a small quantity of pharmaceuticals, and seemed to be used not only in an emergency but also routinely. There are several problems for wholesalers in operating “divided package sales”, such as frequent delivery, delivery cost and information supply. Pharmacies should obtain a small quantity of pharmaceuticals by the routine delivery and should share the delivery cost. Pharmaceutical manufacturers’ cooperation in printing necessary information on each immediate container will be useful. Though there could be alternative ways of obtaining a small quantity of pharmaceuticals, all of them have the matter of delivery. We believe “divided package sales” will contribute to this situation.
- 公益社団法人 日本薬学会の論文
- 2001-01-01
著者
-
KUDO Ichiro
Department of Health Chemistry, School of Pharmaceutical Sciences, Showa University
-
Suzuki R
Toho Yakuhin Co. Ltd.
-
Kudo Ichiro
Department Of Health Chemicals School Of Pharmaceutical Science Showa University
-
SHIRAGAMI Makoto
Department of Health Chemicals, School of Pharmaceutical Science, Showa University
-
MORIKUBO Mitsuo
Toho Yakuhin Co. Ltd.
-
SUZUKI Ryuta
Toho Yakuhin Co. Ltd.
-
Shiragami Makoto
Department Of Health Chemicals School Of Pharmaceutical Science Showa University
-
白神 誠
Department of Health Chemicals, School of Pharmaceutical Science, Showa University
-
森久保 光男
Toho Yakuhin Co. Ltd.
-
鈴木 竜太
Toho Yakuhin Co. Ltd.
関連論文
- Induction of PYPAF1 during In Vitro Maturation of Mouse Mast Cells
- Papyriflavonol A from Broussonetia papyrifera Inhibits the Passive Cutaneous Anaphylaxis Reaction and Has a Secretory Phospholipase A_2-Inhibitory Activity
- Enhanced Degradation of Phospholipids by Phospholipase A2 in Liver of Carbon Tetrachloride-Treated Rat
- Characterization of Heparin Low-Affinity Phospholipase A_1 Present in Brain and Testicular Tissue
- Phospholipase A_2
- Lysophosphatidylserine Enhances Exogenous Type II Phospholipase A_2-Induced Activation of Rat Serosal Mast Cells
- Exogenous Type-II Phospholipase A_2 Stimulates Prostaglandin Synthesis in Rat Liver-Derived BRL-3A Cells in the Presence of Tumor Necrosis Factor α
- Progress and Problems in the Prescribing/Dispensing Split and "Divided Package Sales" by Wholesalers
- 81. Cerebral Circulation in an early stage of Head Injury.
- 37. Local Significance of Cerebral Circulation.
- Association of N-myc Downregulated Gene 1 with Heat-Shock Cognate Protein 70 in Mast Cells (Biochemistry/Molecular Biology)
- N-Myc Downregulated Gene 1 Is a Phosphorylated Protein in Mast Cells (Biochemistry/Molecular Biology)
- Activation of Phospholipase A_2 and Acylation of Lysophospholiplds: The Major Regulators for Platelet Activating Factor Production in Rat Neutrophils^1
- Secretory Phospholipase A_2(Diversity of Phospholipase A_2 Enzymes)
- Induction of PYPAF1 during In Vitro Maturation of Mouse Mast Cells